Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes have?
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes has 2,581 citations in the OpenAlex counts ScholarIQ stores.
When was Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes published?
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes has 2006 year in the ScholarIQ index.
What is the open-access status of Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes?
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes has green oa status in the ScholarIQ index.
What is the DOI of Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes?
The DOI for Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes is on the source record.
What is the PMID of Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes?
The PMID for Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes is on the source record.
What is the OpenAlex record for Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes?
The OpenAlex for Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes is on the source record.